Whitepaper: Uncover specific correlations in heterogeneous cell populations during drug development
Posted: 3 October 2016 | Bio-Rad Laboratories | No comments yet
Integrating the S3e™ Cell Sorter into sample preparation upstream of the QX200™ Droplet Digital System provided details about cell subpopulations that would have been undetectable in heterogeneous populations…
Biological samples are often composed of various cell types, making it critically important to characterize the genetic components of cell samples. Having the ability to understand subpopulations may uncover correlations in cancer or other diseases.
By refining test results and uncovering specific correlations in heterogeneous cell populations, targeting is enhanced as well as the possibility to develop a useful treatment or drug molecule. In this study, a mixed cell culture was sorted using the S3e™ Cell Sorter in order to obtain an enriched subpopulation. The resulting subpopulation was then measured using the QX 200™ Droplet Digital™ PCR (ddPCR™) System to gather precise information about the sample’s genetic makeup. Integrating the S3e Cell Sorter into the sample preparation upstream of the QX 200 System provided specific as well as informative details from these cells of interest in contrast to the information ordinarily obtained from bulk heterogeneous populations.
This whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- Article: Understanding potency in cell and gene therapy development
- Article: Challenges in developing CAR T-cell therapies
- Video: Did you know that ddPCR technology offers lower variability for viral titer determination?
- Infographic: Detecting Mycoplasma contamination in your cell culture with confidence
- Antibody pipelines – the pharma perspective